DAFNA Capital Management LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 54 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$284,000
-31.1%
35,9770.0%0.20%
-41.7%
Q1 2017$412,000
-12.0%
35,977
-10.5%
0.35%
-15.3%
Q4 2016$468,000
-61.2%
40,192
-55.3%
0.41%
-51.0%
Q3 2016$1,205,00090,0000.84%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders